So far, Abbott has made the most progress and has begun large clinical trials to test its dual CGM-CKM
REPRODUCTION 146 , R21R35 (2013)
The interventions also aimed at improving metabolic profile
Certain choline TMA lyase inhibitors can help lower plasma TMAO levels and improve atherosclerosis and thrombosis
#Type2Diabetes #DiabetesCare #GLP1 #DPP4 #GlycaemicControl #WeightManagement #CardiovascularHealth To view or add a comment, sign in BF Biosciences Limited has announced the commercial launch of Zeptide (Tirzepatide), a next-generation therapy for Type 2 diabetes and obesity, now available in Pakistan in Read More: To view or add a comment, sign in Review of GLP-1 agonist use in rheumatology - with benefits beyond DM, obesity, improved survival, reduced major cardiovascular and renal events
Zhang X, Chen Y, Jenkins LW et al (2004) Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury